Ads
related to: new test for prostate screening results- Sign Up for Updates
Sign up to receive the latest data,
case studies, and resources.
- Case Studies
Review real case studies
with real patients.
- Contact Us
Contact our representatives
for product and reimbursement info.
- Find an Imaging Site
Locate the nearest imaging site
or contact customer service.
- Sign Up for Updates
Search results
Results from the WOW.Com Content Network
A team at Heriot-Watt University, Edinburgh, leading the clinical trial said recent testing at the Western General Hospital has shown promising results in screening for the disease. The new ...
The test also significantly reduced unnecessary biopsies for individuals with indolent, low-grade prostate cancer. The results are exciting, but questions remain as to whether the test would ...
For premium support please call: 800-290-4726 more ways to reach us
Prostate cancer screening is the screening process used to detect undiagnosed prostate cancer in men without signs or symptoms. [1] [2] When abnormal prostate tissue or cancer is found early, it may be easier to treat and cure, but it is unclear if early detection reduces mortality rates.
In men aged 55–69 who have been counseled on the known harms and potential benefits of prostate cancer screening, the U.S. Preventive Service Task Force May 2018 statement states, "The use of digital rectal examination as a screening modality is not recommended because there is a lack of evidence on the benefits."
Slawin is a co-discoverer of -2proPSA (P2PSA), [8] [9] a molecular form of prostate specific antigen, which has been shown to improve the accuracy of prostate cancer screening. [10] A multi-center study supported by the National Cancer Institute verified the ability of proPSA to be a valid marker for early detection of prostate cancer. [11]
What Your PSA Test Results Mean. THE PSA IS a good initial “check engine light” for the prostate, says Garrett Pohlman, M.D., a urologist and host of The Prostate Health Podcast. But it can ...
In a separate study of men from the pre prostate cancer screening era managed with watchful waiting (56% over age 70 years), progression to distant metastasis or prostate cancer death was 13.9% and 12.3%, respectively for Gleason score 6 or below, but considerably higher at 18.2 and 22.7%, 30% and 20%, 44.4% and 55.6% for Gleason 3+4, 4+3, and ...
Ads
related to: new test for prostate screening results